Life Sciences
What pharma supply chain transformation means for tax
Supply chain changes affect tax. Involve tax teams from the start.
Disruption exposes flaws in existing pharma supply chains.
Tax considerations of resilience strategies
Relocation, dual sourcing and stockpiling affect tax.
New value drivers affect transfer pricing
Profit allocation may need to change.
Operational considerations for tax teams
Data, systems and documentation.
What tax teams can do now
Join supply chain planning early and model tax impacts.
Summary
Tax should be part of supply chain transformation from the beginning.
Keep reading
Related articles
Article
How biopharma can get the right mix of people and technology for launch success
Biopharma companies need an end-to-end, AI-enabled launch strategy to succeed in a challenging market.
Article
How life sciences legal teams prepare for a technology-driven future
Emerging health technology creates new data flows and new legal and privacy questions for life sciences companies.
Article
How next-generation CRM will reshape the life sciences commercial model
Customer relationship management in life sciences must move from static maps to real-time navigation.